Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

BACKGROUND: There is strong evidence of under-reporting of harms in manuscripts on randomized controlled trials (RCTs) compared with the volume of raw data retrieved from these trials. Many guidelines have been developed to tackle this, but they have failed to address some important issues that woul...

Descripción completa

Detalles Bibliográficos
Autores principales: Honvo, Germain, Bannuru, Raveendhara R., Bruyère, Olivier, Rannou, Francois, Herrero-Beaumont, Gabriel, Uebelhart, Daniel, Cooper, Cyrus, Arden, Nigel, Conaghan, Philip G., Reginster, Jean-Yves, Thomas, Thierry, McAlindon, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509216/
https://www.ncbi.nlm.nih.gov/pubmed/31073927
http://dx.doi.org/10.1007/s40266-019-00667-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509216/
https://www.ncbi.nlm.nih.gov/pubmed/31073927
http://dx.doi.org/10.1007/s40266-019-00667-8

Ejemplares similares